Tracy Cunningham
Hoofd Techniek/Wetenschap/O&O bij AMRYT PHARMA PLC
Actieve functies van Tracy Cunningham
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AMRYT PHARMA PLC | Hoofd Techniek/Wetenschap/O&O | 01-04-2020 | - |
Health Research Board | Directeur/Bestuurslid | - | - |
Loopbaan van Tracy Cunningham
Eerdere bekende functies van Tracy Cunningham
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ASTRAZENECA PLC | Corporate Officer/Principal | - | - |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | 27-06-2022 | - |
Corporate Officer/Principal | 01-04-2020 | 27-06-2022 |
Opleiding van Tracy Cunningham
Royal College of Surgeons | Undergraduate Degree |
Statistieken
Internationaal
Ierland | 4 |
Verenigd Koninkrijk | 3 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Government | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ASTRAZENECA PLC | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Health Research Board | Government |
Amryt Pharma Plc
Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
- Beurs
- Insiders
- Tracy Cunningham
- Ervaring